Article Information
History
- September 18, 2020.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Donald A. Berry†,
- Scott Berry‡,
- Peter Hale§,
- Leah Isakov¶,
- Andrew W. Lo‖&,
- Kien Wei Siah** and
- Chi Heem Wong**
- †MD Anderson and Berry Consultants
- ‡Berry Consultants
- §The Foundation for Vaccine Research
- ¶Seqirus Inc
- ‖MIT Sloan School of Management, CSAIL, Laboratory for Financial Engineering, and EECS, 100 Main Street, E62–618, Cambridge, MA 02142–1347
- **MIT CSAIL, Laboratory for Financial Engineering, and EECS
- ↵&corresponding author (e-mail: alo-admin{at}mit.edu).
Posted September 18, 2020.
A Cost/Benefit Analysis of Clinical Trial Designs for COVID-19 Vaccine Candidates
